[EN] IMIDAZO [1,2A] PYRIDINE DERIVATIVES, THEIR USE AS S1P1 AGONISTS AND METHODS FOR THEIR PRODUCTION [FR] DÉRIVÉS D'IMIDAZO[1,2A]PYRIDINE, LEUR EMPLOI EN TANT QU'AGONISTES DE S1P1 ET LEURS MÉTHODES DE PRODUCTION
The invention is directed to Compounds of Formula I:
as well as methods of making and using the compounds.
本发明涉及式I的化合物,以及制备和使用该化合物的方法。
SAR studies of 3-arylpropionic acids as potent and selective agonists of sphingosine-1-phosphate receptor-1 (S1P1) with enhanced pharmacokinetic properties
作者:Lin Yan、Pei Huo、Jeffrey J. Hale、Sander G. Mills、Richard Hajdu、Carol A. Keohane、Mark J. Rosenbach、James A. Milligan、Gan-Ju Shei、Gary Chrebet、James Bergstrom、Deborah Card、Suzanne M. Mandala
DOI:10.1016/j.bmcl.2006.10.057
日期:2007.2
Structure-activity relationship (SAR) studies of 3-arylpropionic acids-a class of novel S1P(1) selective agonists-by introducing substitution to the propionic acid chain and replacing the adjacent phenyl ring with pyridine led to a series of modified 3-arylpropionic acids with enhanced half-life in rat. These analogs (e.g., cyclopropanecarboxylic acids) exhibited longer half-life in rat than did unmodified 3-arylpropionic acids. This result suggests that metabolic oxidation at the propionic acid chain, particularly at the C3 benzylic position of 3-arylpropionic acids, is probably responsible for their short half-life in rodent. (c) 2006 Elsevier Ltd. All rights reserved.
[EN] IMIDAZO [1,2A] PYRIDINE DERIVATIVES, THEIR USE AS S1P1 AGONISTS AND METHODS FOR THEIR PRODUCTION<br/>[FR] DÉRIVÉS D'IMIDAZO[1,2A]PYRIDINE, LEUR EMPLOI EN TANT QU'AGONISTES DE S1P1 ET LEURS MÉTHODES DE PRODUCTION
申请人:EXELIXIS INC
公开号:WO2010065760A1
公开(公告)日:2010-06-10
The invention is directed to Compounds of Formula (I) as well as methods of making and using the compounds.